RxDoctor Payments Data

Daniel Schipper, PA

Physician Assistant · Lincoln, NENPI 1437392750

Payments from drug & device makers

$4,146in general payments, 2019–2025

Across 29 payments — averaging $142.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Treace Medical Concepts, Inc.$4K
  • Abbott$125
  • Johnson & Johnson$78
  • Impulse Dynamics (USA) Inc.$74
  • Boston Scientific$48
  • Merck$46
  • plus $143 from 6 others

What the payments were for

  • Consulting fees$3,45083%
  • Travel & lodging$1814%
  • Food & beverage$51412%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,146 in reported general payments places this provider in the 90th percentile of 1,127 physician assistant providers in Nebraska.

See all physician assistant providers in Nebraska

Medicare billing

Part B allowed, 2024
$199,244
Medicare patients
976
Services billed
3,759

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban211$166,753
XareltoRivaroxaban76$63,674
EntrestoSacubitril/Valsartan51$36,639
Repatha SureclickEvolocumab48$25,007
Praluent PenAlirocumab19$9,500
Metoprolol Succinate179$2,717
Potassium Chloride103$2,024
Bumetanide45$1,898
Midodrine Hcl30$1,568
Flecainide Acetate58$1,413
Atorvastatin Calcium121$1,359
Amiodarone Hcl45$1,346
Diltiazem 24hr Er (La)Diltiazem Hcl18$1,325
SotalolSotalol Hcl78$1,301
Bisoprolol Fumarate43$1,182

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$78$63,67476 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 1,127 physician assistant providers in Nebraska.

Other physician assistant in Lincoln

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →